CTOs on the Move

BrightCoach

www.bright.coach

 
BrightCoach is a rapidly growing innovator in the Coaching industry. It is a company of talented, experienced, executive business, and life coaches, dedicated to enriching lives and helping our clients achieve their desired goals. BrightCoach works closely with our clients to help them move forward in a unique one-on-one Coaching relationship to create positive change, leadership skills, active self-discovery and extraordinary results in their lives, careers, businesses or organizations. BrightCoach has developed a unique Coaching methodology combining today’s latest science of change within structured, personalized Coaching programs, to help our clients move from where they are - to where they ...
  • Number of Employees: 250-1000
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Planned Parenthood North Central States

Planned Parenthood North Central States (PPNCS) and its subsidiary organizations provide, promote, and protect reproductive and sexual health through high quality care, education and advocacy. A member of America`s most trusted reproductive health care provider, our affiliate is proud to support and operate 29 health centers across our five-state region (Iowa, Minnesota, Nebraska, North Dakota and South Dakota). Each year, we provide health care to nearly 115,000 people and health education to more than 99,000 people in our region.

Can-Med Healthcare

Can-Med Healthcare is a Bedford, NS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Encompass Health System

ENCOMPASS was established in 1985 as a wholly owned for profit subsidiary of the Iowa Foundation for Medical Care (IFMC). IFMC was established in 1972 through the cooperative efforts of business and physicians in response to increasing demands for

Healthcare Purchasing Alliance (HPA)

Healthcare Purchasing Alliance (HPA) is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Telesta Therapeutics

Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.